花辨直播官方版_花辨直播平台官方app下载_花辨直播免费版app下载

USEUROPEAFRICAASIA 中文雙語Fran?ais
World
Home / World / Americas

Brazil to begin Zika vaccine trials in humans

Xinhua | Updated: 2016-09-22 11:00

RIO DE JANEIRO - Brazil will begin testing a vaccine against the mosquito-borne Zika virus in humans in the next two months,a leading researcher told reporters on Tuesday.

The so-called DNA vaccine was jointly developed by Brazil's state-run Butantan Institute and researchers from the United States.

"It is an absolutely revolutionary technology," said Jogre Kalil, director of Butantan Institute, adding that it was also safe even for pregnant women.

The virus is a particular menace to women who are expecting, as it has been linked to microcephaly, a birth defect characterized by infants born with abnormally small heads.

The vaccine is said to work by incorporating Zika DNA, via a synthetically produced Zika virus protein, to induce the body's immune system into fighting off the disease.

The approval of the vaccine will depend on the success of the trials.

According to the World Health Organization, the virus is primarily transmitted through the bite of the aedes aegypti mosquito, which also spreads dengue, chikungunya and yellow fever.

In Latin America, Brazil has been the hardest hit by the virus, which it linked last year to a spike in cases of microcephaly and Guillain-Barre syndrome, which can cause temporary paralysis in people.

Most Viewed in 24 Hours
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US